Figure 4
From: Mir-183 functions as an oncogene via decreasing PTEN in breast cancer cells
The effect of miR-183 on cell cycle progression and cell viability in breast cancer cells. (A) Cell cycle profiles were analyzed using flowcytometry after MCF-7 and MDA-MB-231 cells transfection with miR-183; (G0/G1: **p = 0.0019, **p = 0.0026; S: **p = 0.0012, **p = 0.0074; G2/M: **p = 0.0068, **p = 0.0093). (B) Cell growth viability was measured by MTT assay 48 h after transfection; *p = 0.0395, *p = 0.0127. The un-transfected cells serve as the negative control. *p < 0.05; **p < 0.01; ***p < 0.001. NC negative control.
